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ESTIMATING SOCIODEMOGRAPHICVARIABLES IN A
PHARMACY DATASET:APPLYING DATA FROM US CENSUS
2000
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University of Utah, Salt Lake City, UT, USA
OBJECTIVE: Pharmacy datasets are useful for evaluating drug
costs, patient utilization, and patient adherence. Few have infor-
mation on sociodemographic variables including race, education,
income, and urban/rural designation of the patients’ neighbor-
hoods. We undertook to estimate those variables by linking USA
census 2000 data with one such database. METHODS: We
obtained census data tables for race, median income, education,
and percentage of urban/rural residences by Zone Improvement
Plan (ZIP) codes. Linking to the RxAmerica pharmacy claims
database by 5-digit ZIP, we estimated sociodemographic vari-
ables for a cohort of adult new users of lipid-lowering therapy
with 18-months continuous eligibility. For patients without a
ZIP, pharmacy ZIP was used as a proxy. Four variables were
generated to estimate race, median income, education level,
and urban/rural designation of the patients’ neighborhoods.
RESULTS: A total of 29,667 patients met the inclusion criteria.
Of these, 28,293 (95.4%) had a valid 5-digit ZIP that linked with
one in the census tables; 97.0% of the ZIPs were derived from the
patients’ addresses. Among a sample of 19,458 patients, there
were 4662 unique ZIPs; number of patients within each ZIP
ranged from 1–125 (SD 11.9). The mean observation for income
based on the median income variable reported in the census table
was $45,924 (SD $15,965). The median observation for educa-
tion was at least a high-school diploma; 25% of subjects had an
observation corresponding to at least some college. Most of the
patients had observations for race indicating they were from
predominantly white neighborhoods (63.5% from neighbor-
hoods that were 75% white). Most of the patients also had
observations indicating they were from highly urbanized areas
(74.0% from neighborhoods that were 75% urban). CON-
CLUSION: Census tables may be useful for estimating sociode-
mographic variables for pharmacy claims analyses. Future work
should focus on the validity of these variables for estimating
sociodemographic variables.
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Objective: The purpose of this study is to show the methodology
for preprocessing and analyzing large health care databases. We
consider working with large databases of clinical information
such as National Inpatient Sample (NIS), and Thomson MedStat
MarketScan data containing all patient claims in 40 million
observations. METHODS: We can deﬁne a group of procedures
and treat them as one episode to investigate the frequency of
occurrence. In many studies, only the primary procedure and
diagnosis are considered when there are more than one proce-
dure and diagnosis columns, but important information could be
in those other columns. In our database used for the study, there
are ﬁfteen procedure and ﬁfteen diagnosis columns that we use to
ﬁnd episodes of patient care. We also combine information from
multiple datasets: inpatient, outpatient, pharmacy information.
Another approach is to consider a sequence of treatments on
patients and to study the effectiveness of treatment by looking at
this sequence for each patient. Studying the physician decisions
and the results of them is interesting to many health care orga-
nizations. RESULTS: Powerful statistical software is required to
work with large data ﬁles. We used SAS Enterprise Guide and the
RXMATCH function to summarize codes deﬁning a speciﬁc
diagnosis, using multiple information sources. An alternative
approach is to use SAS Text Miner. We combine columns using
the CATX function. Then we use SAS Text Miner on the deﬁned
text string; the terms window in the output gives the frequency
and number of documents. We use Text Miner features such as
“Treating as equivalent terms”, “Sorting” and “Filtering” to get
summaries of different diagnosis or procedures. We successfully
deﬁned episodes of care. CONCLUSIONS: Preprocessing is an
essential aspect of outcomes research. Dealing with multiple data
sources is essential.
RESEARCH ON METHODS & CONCEPTUAL
PAPERS—Modeling Studies
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Incremental costs and effectiveness may be correlated if patients
receiving the most health beneﬁt from an intervention tend to be
those who incur greater (or lesser) incremental cost. Such corre-
lation has the potential to bias the synthesis of cost-effectiveness
evidence, yet is infrequently reported. The objective of this study
was to assess the sensitivity of an incremental cost-effectiveness
ratio (ICER) for interventions A vs C, estimated indirectly from
studies of A vs B and B vs C, to correlations between incremental
cost and effect. Incremental costs and effects of interventions A vs
B and B vs C were simulated from lognormal and Normal dis-
tributions respectively of given mean, standard deviation (SD)
and cost-effectiveness correlation. The distribution of the ICER
for interventions A vs C was calculated. Results from various
parameter choices were compared. One parameter set choice was
that the mean (SD) incremental cost of A vs B was $100,000
($40,000) for a health beneﬁt of ten(2) and that the incremental
cost of B vs C was $200,000 ($50,000) for a health beneﬁt of
12(2). For the parameter set described, the mean (SD) ICER of
intervention A vs C assuming no correlation between incremental
costs and health effects was $13,760 ($2637). Varying the two
correlation parameters between -1 and +1 altered the mean
ICER by up to $200 and the ICER’s SD by up to $1679. The
ICER’s mean was fairly insensitive to the two correlation param-
eters but its SD was more sensitive. Correlations between cost
and effectiveness can therefore be expected to be more important
in questions of decision uncertainty rather than in the estimation
with best existing knowledge of relative cost-effectiveness. More
generally, sensitivity was greater when distributional variance
and skewness of incremental cost and health beneﬁt were greater.
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OBJECTIVE: This paper introduces a method that combines
the propensity score matching and interrupted (segmented) time
series models to measure the effect of guidelines on outcomes
measures. MODEL: Propensity score matching is used to bal-
anced the groups before the trend is analyzed. The Kitchen sink
approach is used for propensity score matching. Interrupted time
series models applied over the matched sample. The time series
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